1. Screening will be done within 2 weeks before starting treatment, and will include all parameters listed below, (except for pharmacokinetics, AEs/concomitant medications, and toxicity assessments) as well as informed consent, patient eligibility, medical history, a pregnancy test (if indicated), EKG, and urinalysis.